JAK2V617F mutation in patients with thrombosis: to screen or not to screen?-Reference-Cited by-同舟云学术

JAK2V617F mutation in patients with thrombosis: to screen or not to screen?

Published:2010-12-01 Issue:2 Volume:33 Page:117-124
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:

Author:

XAVIER S. G.,GADELHA T.,REZENDE S. M.,ZALCBERG I. R.,SPECTOR N.

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Reference62 articles.

1. Clinical JAK2V617F mutation testing: limited utility for general hospital patients with venous and arterial thromboses in common locations;Abel;American Journal of Hematology,2008

2. Akada H. Yan D. Zou H. Fiering S. Hutchison R.E. Mohi M.G. 2010 Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease 10.1182/blood-2009-04-215848

3. Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients;Alvarez-Larran;Leukemia,2007

4. Clinical implications of the JAK2V617F mutation in essential thrombocythemia;Antonioli;Leukemia,2005

5. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status;Arellano-Rodrigo;Haematologica,2006

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Evaluation of Polycythemia Vera at High Altitude;Clinical Laboratory;2024

2. Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology;Diagnostics;2023-01-03

3. Einfluss der klonalen Hämatopoese auf nicht-hämatologische Erkrankungen und Alterungsprozesse;Die Innere Medizin;2022-10-10

4. Relevance of early diagnosis in polycythemia vera and essential thrombocythemia: A single center’s experience;Revista Clínica Española (English Edition);2021-10

5. Importancia del diagnóstico precoz en policitemia vera y trombocitemia esencial. Experiencia de un centro;Revista Clínica Española;2021-08